Cardiogen
The heart slot in a Russian bioregulator rotation, run 10 to 20 days at a time. You will feel nothing, and the proof is Russian only.
What it is
Cardiogen is the heart peptide in the Russian bioregulator family, bought mostly by people who already rotate those courses or who watched a parent go through heart disease. It is a cheap, low-risk add-on that you will not feel, and nothing we can cite shows it does anything for a human heart.
Two kinds of people buy Cardiogen. The first already runs the Khavinson rotation, a short course of a different bioregulator every few months: Epitalon for sleep and aging, Pinealon for the brain, Cartalax for joints. Cardiogen is the heart slot in that calendar. The second is someone in their forties or fifties whose father had a heart attack at sixty, or whose mother lives with heart failure, who already does the basics and wants one more low-risk thing on top. Neither is treating a heart problem. If you have angina, an arrhythmia or heart failure, Cardiogen is not part of the answer; your cardiologist's plan is.
What you will notice is nothing, and that is the honest expectation, not a warning about a slow start. There is no energy lift, no lower resting heart rate, no easier run. The bioregulator idea is that a very short peptide nudges aging heart cells back toward normal upkeep, which nobody can feel. The best realistic result is a number months later: a home blood pressure log or a follow-up echo (a heart ultrasound) that held steady or moved a little after a few courses. Even then you could not tell whether Cardiogen did it, your training did, or nothing did.
The course is 100 to 300 mcg as a subQ shot once a day for 10 to 20 days (up to 30), then a few months off before the next one; most people run two or three courses a year. The gap is not about it wearing off: the effect is meant to carry on for months after a course, so there is nothing to gain from running it straight through, and the exact spacing is up to you. 200 mcg is the usual dose, and time of day and food do not matter. The cost reality is the vial: 20 mg mixed with 3 ml is 100 doses at 200 mcg, and a course uses only 1 to 9 mg of it. A mixed vial keeps about four weeks, so in practice you buy one vial per course and throw most of it out, or split it with someone running the same course. At about 67 mcg per unit, 200 mcg is a 3-unit draw, so pull slowly and check the line. The common mistake is a milligram dose copied from a gray-market sheet, which empties the vial in a week and buys nothing.
We grade it animal 2, human 1, and both numbers rest on work from the St. Petersburg institute that created the bioregulators: cell and old-animal studies on heart tissue, plus small Russian clinical reports in older people. No Western lab has repeated any of it, there are no controlled trials, and there is no human outcome we can cite: no fewer heart attacks, no better heart function, no longer life. The idea is plausible and the result is unknown.
If you want to do something for your heart that you can measure, start where the proof is: a home blood pressure cuff, a lipid panel you act on, and three to five training sessions a week, some of them hard enough to breathe heavily. Those move real numbers within months. If what you want is a longevity bioregulator, Epitalon is the better-studied pick on this site and the one people actually notice, through sleep. SS-31 is the heart-and-mitochondria option with human trial data, and Vesugen is the blood-vessel sibling if you are building the full rotation. Cardiogen only makes sense once the basics are done, as a cheap add-on you accept you will never be able to judge.
What people use it for
Aging heart muscle
Early daysThe institute that developed the bioregulators reports, in cell cultures and aged animals, that Cardiogen shifts heart cells toward a younger pattern of activity. We have not found any lab outside that group repeating it. Read it as the reason the peptide exists, not as evidence that it helps you.
Heart health in older people
Early daysThe human grade of 1 stands for small Russian clinical reports in older adults. We cannot point you to one with checkable outcomes, and none measured heart attacks, heart function or survival against a control group. There is no human result we can cite for any heart number.
A longevity rotation
Early daysMost people run Cardiogen inside a rotation with Epitalon and Vesugen. No study has tested that rotation or shown that adding the heart peptide changes anything. Of the three, Epitalon has the deepest research and the one effect people reliably notice, better sleep.
How people use it
Safety, in brief
Things people sometimes notice
- A little redness or itching at the injection site
- Nothing else you would notice; effects in people have never been mapped
The full picture — stop signs and who should talk to a doctor first — is on the dosing guide.
Sources
The labels and studies behind this page. Each link opens the original on PubMed, DailyMed or ClinicalTrials.gov.
- The effect of the amino acids and cardiogen on the development of myocard tissue culture from young and old rats
- Senescence-Associated Secretory Phenotype of Cardiovascular System Cells and Inflammaging: Perspectives of Peptide Regulation
- Peptidergic regulation of age-related alterations in the cardiovascular system